SNPing away at complex diseases: Analysis of single-nucleotide polymorphisms around APOE in alzheimer disease

Eden R Martin, E. H. Lai, John Gilbert, A. R. Rogala, A. J. Afshari, J. Riley, K. L. Finch, J. E. Stevens, K. J. Livak, B. D. Slotterbeck, S. H. Slifer, L. L. Warren, R. M. Conneally, D. E. Schmechel, I. Purvis, Margaret A Pericak-Vance, A. D. Roses, Jeffery M Vance

Research output: Contribution to journalArticle

314 Citations (Scopus)

Abstract

There has been great interest in the prospects of using single- nucleotide polymorphisms (SNPs) in the search for complex disease genes, and several initiatives devoted to the identification and mapping of SNPs throughout the human genome are currently underway. However, actual data investigating the use of SNPs for identification of complex disease genes are scarce. To begin to look at issues surrounding the use of SNPs in complex disease studies, we have initiated a collaborative SNP mapping study around APOE, the well-established susceptibility gene for late-onset Alzheimer disease (AD). Sixty SNPs in a 1.5-Mb region surrounding APOE were genotyped in samples of unrelated cases of AD, in controls, and in families with AD. Standard tests were conducted to look for association of SNP alleles with AD, in cases and controls. We also used family-based association analyses, including recently developed methods to look for haplotype association. Evidence of association (P ≤ .05) was identified for 7 of 13 SNPs, including the APOE-4 polymorphism, spanning 40 kb on either side of APOE. As expected, very strong evidence for association with AD was seen for the APOE-4 polymorphism, as well as for two other SNPs that lie <16 kb from APOE. Haplotype analysis using family data increased significance over that seen in single-locus tests for some of the markers, and, for these data, improved localization of the gene. Our results demonstrate that associations can be detected at SNPs near a complex disease gene. We found that a high density of markers will be necessary in order to have a good chance of including SNPs with detectable levels of allelic association with the disease mutation, and statistical analysis based on haplotypes can provide additional information with respect to tests of significance and fine localization of complex disease genes.

Original languageEnglish
Pages (from-to)383-394
Number of pages12
JournalAmerican Journal of Human Genetics
Volume67
Issue number2
DOIs
StatePublished - Aug 23 2000
Externally publishedYes

Fingerprint

Single Nucleotide Polymorphism
Alzheimer Disease
Haplotypes
Genes
Nucleotide Mapping
Human Genome
Alleles
Mutation

ASJC Scopus subject areas

  • Genetics

Cite this

SNPing away at complex diseases : Analysis of single-nucleotide polymorphisms around APOE in alzheimer disease. / Martin, Eden R; Lai, E. H.; Gilbert, John; Rogala, A. R.; Afshari, A. J.; Riley, J.; Finch, K. L.; Stevens, J. E.; Livak, K. J.; Slotterbeck, B. D.; Slifer, S. H.; Warren, L. L.; Conneally, R. M.; Schmechel, D. E.; Purvis, I.; Pericak-Vance, Margaret A; Roses, A. D.; Vance, Jeffery M.

In: American Journal of Human Genetics, Vol. 67, No. 2, 23.08.2000, p. 383-394.

Research output: Contribution to journalArticle

Martin, ER, Lai, EH, Gilbert, J, Rogala, AR, Afshari, AJ, Riley, J, Finch, KL, Stevens, JE, Livak, KJ, Slotterbeck, BD, Slifer, SH, Warren, LL, Conneally, RM, Schmechel, DE, Purvis, I, Pericak-Vance, MA, Roses, AD & Vance, JM 2000, 'SNPing away at complex diseases: Analysis of single-nucleotide polymorphisms around APOE in alzheimer disease', American Journal of Human Genetics, vol. 67, no. 2, pp. 383-394. https://doi.org/10.1086/303003
Martin, Eden R ; Lai, E. H. ; Gilbert, John ; Rogala, A. R. ; Afshari, A. J. ; Riley, J. ; Finch, K. L. ; Stevens, J. E. ; Livak, K. J. ; Slotterbeck, B. D. ; Slifer, S. H. ; Warren, L. L. ; Conneally, R. M. ; Schmechel, D. E. ; Purvis, I. ; Pericak-Vance, Margaret A ; Roses, A. D. ; Vance, Jeffery M. / SNPing away at complex diseases : Analysis of single-nucleotide polymorphisms around APOE in alzheimer disease. In: American Journal of Human Genetics. 2000 ; Vol. 67, No. 2. pp. 383-394.
@article{80eb6643bc83410790b84c9c7cbabc92,
title = "SNPing away at complex diseases: Analysis of single-nucleotide polymorphisms around APOE in alzheimer disease",
abstract = "There has been great interest in the prospects of using single- nucleotide polymorphisms (SNPs) in the search for complex disease genes, and several initiatives devoted to the identification and mapping of SNPs throughout the human genome are currently underway. However, actual data investigating the use of SNPs for identification of complex disease genes are scarce. To begin to look at issues surrounding the use of SNPs in complex disease studies, we have initiated a collaborative SNP mapping study around APOE, the well-established susceptibility gene for late-onset Alzheimer disease (AD). Sixty SNPs in a 1.5-Mb region surrounding APOE were genotyped in samples of unrelated cases of AD, in controls, and in families with AD. Standard tests were conducted to look for association of SNP alleles with AD, in cases and controls. We also used family-based association analyses, including recently developed methods to look for haplotype association. Evidence of association (P ≤ .05) was identified for 7 of 13 SNPs, including the APOE-4 polymorphism, spanning 40 kb on either side of APOE. As expected, very strong evidence for association with AD was seen for the APOE-4 polymorphism, as well as for two other SNPs that lie <16 kb from APOE. Haplotype analysis using family data increased significance over that seen in single-locus tests for some of the markers, and, for these data, improved localization of the gene. Our results demonstrate that associations can be detected at SNPs near a complex disease gene. We found that a high density of markers will be necessary in order to have a good chance of including SNPs with detectable levels of allelic association with the disease mutation, and statistical analysis based on haplotypes can provide additional information with respect to tests of significance and fine localization of complex disease genes.",
author = "Martin, {Eden R} and Lai, {E. H.} and John Gilbert and Rogala, {A. R.} and Afshari, {A. J.} and J. Riley and Finch, {K. L.} and Stevens, {J. E.} and Livak, {K. J.} and Slotterbeck, {B. D.} and Slifer, {S. H.} and Warren, {L. L.} and Conneally, {R. M.} and Schmechel, {D. E.} and I. Purvis and Pericak-Vance, {Margaret A} and Roses, {A. D.} and Vance, {Jeffery M}",
year = "2000",
month = "8",
day = "23",
doi = "10.1086/303003",
language = "English",
volume = "67",
pages = "383--394",
journal = "American Journal of Human Genetics",
issn = "0002-9297",
publisher = "Cell Press",
number = "2",

}

TY - JOUR

T1 - SNPing away at complex diseases

T2 - Analysis of single-nucleotide polymorphisms around APOE in alzheimer disease

AU - Martin, Eden R

AU - Lai, E. H.

AU - Gilbert, John

AU - Rogala, A. R.

AU - Afshari, A. J.

AU - Riley, J.

AU - Finch, K. L.

AU - Stevens, J. E.

AU - Livak, K. J.

AU - Slotterbeck, B. D.

AU - Slifer, S. H.

AU - Warren, L. L.

AU - Conneally, R. M.

AU - Schmechel, D. E.

AU - Purvis, I.

AU - Pericak-Vance, Margaret A

AU - Roses, A. D.

AU - Vance, Jeffery M

PY - 2000/8/23

Y1 - 2000/8/23

N2 - There has been great interest in the prospects of using single- nucleotide polymorphisms (SNPs) in the search for complex disease genes, and several initiatives devoted to the identification and mapping of SNPs throughout the human genome are currently underway. However, actual data investigating the use of SNPs for identification of complex disease genes are scarce. To begin to look at issues surrounding the use of SNPs in complex disease studies, we have initiated a collaborative SNP mapping study around APOE, the well-established susceptibility gene for late-onset Alzheimer disease (AD). Sixty SNPs in a 1.5-Mb region surrounding APOE were genotyped in samples of unrelated cases of AD, in controls, and in families with AD. Standard tests were conducted to look for association of SNP alleles with AD, in cases and controls. We also used family-based association analyses, including recently developed methods to look for haplotype association. Evidence of association (P ≤ .05) was identified for 7 of 13 SNPs, including the APOE-4 polymorphism, spanning 40 kb on either side of APOE. As expected, very strong evidence for association with AD was seen for the APOE-4 polymorphism, as well as for two other SNPs that lie <16 kb from APOE. Haplotype analysis using family data increased significance over that seen in single-locus tests for some of the markers, and, for these data, improved localization of the gene. Our results demonstrate that associations can be detected at SNPs near a complex disease gene. We found that a high density of markers will be necessary in order to have a good chance of including SNPs with detectable levels of allelic association with the disease mutation, and statistical analysis based on haplotypes can provide additional information with respect to tests of significance and fine localization of complex disease genes.

AB - There has been great interest in the prospects of using single- nucleotide polymorphisms (SNPs) in the search for complex disease genes, and several initiatives devoted to the identification and mapping of SNPs throughout the human genome are currently underway. However, actual data investigating the use of SNPs for identification of complex disease genes are scarce. To begin to look at issues surrounding the use of SNPs in complex disease studies, we have initiated a collaborative SNP mapping study around APOE, the well-established susceptibility gene for late-onset Alzheimer disease (AD). Sixty SNPs in a 1.5-Mb region surrounding APOE were genotyped in samples of unrelated cases of AD, in controls, and in families with AD. Standard tests were conducted to look for association of SNP alleles with AD, in cases and controls. We also used family-based association analyses, including recently developed methods to look for haplotype association. Evidence of association (P ≤ .05) was identified for 7 of 13 SNPs, including the APOE-4 polymorphism, spanning 40 kb on either side of APOE. As expected, very strong evidence for association with AD was seen for the APOE-4 polymorphism, as well as for two other SNPs that lie <16 kb from APOE. Haplotype analysis using family data increased significance over that seen in single-locus tests for some of the markers, and, for these data, improved localization of the gene. Our results demonstrate that associations can be detected at SNPs near a complex disease gene. We found that a high density of markers will be necessary in order to have a good chance of including SNPs with detectable levels of allelic association with the disease mutation, and statistical analysis based on haplotypes can provide additional information with respect to tests of significance and fine localization of complex disease genes.

UR - http://www.scopus.com/inward/record.url?scp=0033863391&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033863391&partnerID=8YFLogxK

U2 - 10.1086/303003

DO - 10.1086/303003

M3 - Article

C2 - 10869235

AN - SCOPUS:0033863391

VL - 67

SP - 383

EP - 394

JO - American Journal of Human Genetics

JF - American Journal of Human Genetics

SN - 0002-9297

IS - 2

ER -